Compare
Hexcel Corp vs AdvanSix Inc. vs DuPont de Nemours, Inc. vs Eastman Chemical Co
| Latest fiscal year | Hexcel Corp HXL | AdvanSix Inc. ASIX | DuPont de Nemours, Inc. DD | Eastman Chemical Co EMN |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $1.89B | $1.52B | $6.85B | $8.75B |
| Revenue growth (YoY) | -0.5% | +0.3% | +1.9% | -6.7% |
| Gross margin | 23.0% | 10.8% (computed) | n/a | 21.1% |
| Operating margin | 9.1% | n/a | n/a | n/a |
| Net margin | 5.8% | 3.2% | -11.4% | 5.4% |
| Net income | $109.40M | $49.29M | -$779.00M | $474.00M |
| EPS (Diluted) | n/a | $1.80 | -$1.86 | $4.10 |
| Operating cash flow | $230.50M | $122.86M | $560.00M | $970.00M |
| Free cash flow | $157.20M | $6.42M | $227.00M | $424.00M |
| Cash & equivalents | $71.00M | $19.77M | $715.00M | $566.00M |
| Total assets | $2.70B | $1.71B | $21.57B | $14.86B |
| Total liabilities | $1.45B | $890.93M | $7.47B | $8.82B |
| Shareholders' equity | $1.25B | $815.22M | $14.10B | $5.96B |
| Return on year-end equity | 8.7% | 6.0% | -5.5% | 8.0% |
| Shares outstanding | 75.70M | 26.86M | n/a | 223.94M |
Revenue, most recent five fiscal years
| Fiscal year | Hexcel Corp | AdvanSix Inc. | DuPont de Nemours, Inc. | Eastman Chemical Co |
|---|---|---|---|---|
| Latest | $1.89B Ended 2025-12-31 | $1.52B Ended 2025-12-31 | $6.85B Ended 2025-12-31 | $8.75B Ended 2025-12-31 |
| 1 year earlier | $1.90B Ended 2024-12-31 | $1.52B Ended 2024-12-31 | $6.72B Ended 2024-12-31 | $9.38B Ended 2024-12-31 |
| 2 years earlier | $1.79B Ended 2023-12-31 | $1.53B Ended 2023-12-31 | $6.61B Ended 2023-12-31 | $9.21B Ended 2023-12-31 |
| 3 years earlier | $1.58B Ended 2022-12-31 | $1.95B Ended 2022-12-31 | $13.02B Ended 2022-12-31 | $10.58B Ended 2022-12-31 |
| 4 years earlier | $1.32B Ended 2021-12-31 | $1.68B Ended 2021-12-31 | $12.57B Ended 2021-12-31 | $10.48B Ended 2021-12-31 |